Trial Profile
Effect of Vitamin D and Omega-3 Fatty Acids on Blood Pressure and Hypertension
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 23 Jan 2018
At a glance
- Drugs Colecalciferol (Primary) ; Omega-3-acid ethyl esters (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms VITAL-Hypertension
- 17 Jan 2018 Planned End Date changed from 1 Oct 2017 to 1 Dec 2018.
- 17 Jan 2018 Planned primary completion date changed from 1 Oct 2017 to 1 Dec 2018.
- 15 Aug 2014 Planned End Date changed from 1 Jun 2016 to 1 Oct 2017 as reported by ClinicalTrials.gov record.